Product NDC: | 10019-646 |
Proprietary Name: | SUPRANE |
Non Proprietary Name: | DESFLURANE |
Active Ingredient(s): | 240 mL/240mL & nbsp; DESFLURANE |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-646 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020118 |
Marketing Category: | NDA |
Start Marketing Date: | 19920918 |
Package NDC: | 10019-646-24 |
Package Description: | 6 BOTTLE, GLASS in 1 CARTON (10019-646-24) > 240 mL in 1 BOTTLE, GLASS (10019-646-60) |
NDC Code | 10019-646-24 |
Proprietary Name | SUPRANE |
Package Description | 6 BOTTLE, GLASS in 1 CARTON (10019-646-24) > 240 mL in 1 BOTTLE, GLASS (10019-646-60) |
Product NDC | 10019-646 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DESFLURANE |
Dosage Form Name | LIQUID |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 19920918 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DESFLURANE |
Strength Number | 240 |
Strength Unit | mL/240mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |